Cargando…

The LRP1/CD91 ligands, tissue-type plasminogen activator, α(2)-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling

LDL Receptor-related Protein-1 (LRP1/CD91) binds diverse ligands, many of which activate cell-signaling. Herein, we compared three LRP1 ligands that inhibit inflammatory responses triggered by lipopolysaccharide (LPS), including: enzymatically-inactive tissue-type plasminogen activator (EI-tPA); act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantuano, Elisabetta, Azmoon, Pardis, Banki, Michael A., Gunner, Cory B., Gonias, Steven L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585055/ https://www.ncbi.nlm.nih.gov/pubmed/36266319 http://dx.doi.org/10.1038/s41598-022-22498-1

Ejemplares similares

An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length protein
por: Mantuano, Elisabetta, et al.
Publicado: (2023)

Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages
por: Das, Lipsa, et al.
Publicado: (2019)

Cellular prion protein in human plasma–derived extracellular vesicles promotes neurite outgrowth via the NMDA receptor–LRP1 receptor system
por: Gonias, Steven L., et al.
Publicado: (2022)

Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines
por: Pontecorvi, Paola, et al.
Publicado: (2019)

Indomethacin Disrupts the Formation of β-Amyloid Plaques via an α2-Macroglobulin-Activating lrp1-Dependent Mechanism
por: Guan, Pei-Pei, et al.
Publicado: (2021)

Activated Alpha-2 Macroglobulin Improves Insulin Response via LRP1 in Lipid-Loaded HL-1 Cardiomyocytes
por: Actis Dato, Virginia, et al.
Publicado: (2021)

alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor
Publicado: (1995)

Prion Protein Paralog Doppel Protein Interacts with Alpha-2-Macroglobulin: A Plausible Mechanism for Doppel-Mediated Neurodegeneration
por: Benvegnù, Stefano, et al.
Publicado: (2009)

Activated α(2)-Macroglobulin Regulates LRP1 Levels at the Plasma Membrane through the Activation of a Rab10-dependent Exocytic Pathway in Retinal Müller Glial Cells
por: Jaldín-Fincati, Javier R., et al.
Publicado: (2019)

Correction: Prion Protein Paralog Doppel Protein Interacts with Alpha-2-Macroglobulin: A Plausible Mechanism for Doppel-Mediated Neurodegeneration
por: Benvegnù, Stefano, et al.
Publicado: (2009)

Low-Density Lipoprotein Receptor Related protein-1 (LRP1)-Dependent Cell Signaling Promotes Neurotrophic Activity in Embryonic Sensory Neurons
por: Yamauchi, Kazuyo, et al.
Publicado: (2013)

Heparin‐binding Epidermal Growth Factor‐like Growth Factor: p91 Activation, Induction of Plasminogen Activator/Plasminogen Activator Inhibitor, and Tubular Morphogenesis in Human Microvascular Endothelial Cells
por: Ushiro, Shin, et al.
Publicado: (1996)

Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation
por: Kromann-Hansen, Tobias, et al.
Publicado: (2018)

Differential Modulation of TCF/LEF-1 Activity by the Soluble LRP6-ICD
por: Beagle, Brandon, et al.
Publicado: (2010)

Inactivation of α(2)-Macroglobulin by Activated Human Polymorphonuclear Leukocytes
por: Deby-Dupont, G., et al.
Publicado: (1994)

Metal Ions Bound to Prion Protein Affect its Interaction with Plasminogen Activation System
por: Borumand, Maryam, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor 1 Functions as a Urokinase Response Modifier at the Level of Cell Signaling and Thereby Promotes Mcf-7 Cell Growth
por: Webb, Donna J., et al.
Publicado: (2001)

Apolipoprotein E-Containing Lipoproteins and LRP1 Protect From NMDA-Induced Excitotoxicity Associated With Reducing α2-Macroglobulin in Müller Glia
por: Hayashi, Hideki, et al.
Publicado: (2021)

The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres
por: Gilder, Andrew S., et al.
Publicado: (2018)

Oxidized phospholipids are ligands for LRP6
por: Wang, Lei, et al.
Publicado: (2018)

Binding of α2ML1 to the Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) Reveals a New Role for LRP1 in the Human Epidermis
por: Galliano, Marie-Florence, et al.
Publicado: (2008)

Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival
por: Gonias, Steven L., et al.
Publicado: (2017)

Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells
por: Roy, Ananya, et al.
Publicado: (2015)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91–106
por: Uchiyama, Keiji, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia
por: van Oort, Pouline M., et al.
Publicado: (2019)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor level in individuals of advanced age
por: Wlazel, Rafal N., et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)

The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin
Publicado: (1990)

Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
por: Wyatt, Amy R., et al.
Publicado: (2013)

Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor‐1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
por: Corban, Michel T., et al.
Publicado: (2018)

Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
por: Wittenhagen, Per, et al.
Publicado: (2011)

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
por: Spinale, Joann M., et al.
Publicado: (2014)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
por: Erkut, Nergiz, et al.
Publicado: (2016)

Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
por: Wlazeł, Rafał Nikodem, et al.
Publicado: (2018)

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
por: Böcskei, Renáta M., et al.
Publicado: (2019)

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
por: Bocskei, Renata Marietta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9jq7drvn67p3c85n475a8uvo4e